To evaluate the bioavailability of a tablet of AZD1656

Study identifier:D1020C00010

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Randomized, Open, Single-Dose, Single-Centre, cross-over, Phase I Study in type 1 diabetes mellitus patients to estimate the extent and rate of absorption of AZD1656 after administration of a tablet formulation in the fasting state and just before food in comparison with an oral suspension of AZD1

Medical condition

Type 1 Diabetes

Phase

Phase 1

Healthy volunteers

No

Study drug

AZD1656

Sex

All

Actual Enrollment

11

Study type

Interventional

Age

20 Years - 65 Years

Date

Study Start Date: 01 Dec 2008
Primary Completion Date: 01 Mar 2009
Study Completion Date: 01 Sept 2009

Study design

Allocation: Randomized
Endpoint Classification: Bio-availability Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria